Review



mouse monoclonal anti cln2 tpp1  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology mouse monoclonal anti cln2 tpp1
    KEY RESOURCES TABLE
    Mouse Monoclonal Anti Cln2 Tpp1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal anti cln2 tpp1/product/Santa Cruz Biotechnology
    Average 93 stars, based on 11 article reviews
    mouse monoclonal anti cln2 tpp1 - by Bioz Stars, 2026-06
    93/100 stars

    Images

    1) Product Images from "NPC1-mTORC1 signaling Couples Cholesterol Sensing to Organelle Homeostasis and is a Targetable Pathway in Niemann-Pick type C"

    Article Title: NPC1-mTORC1 signaling Couples Cholesterol Sensing to Organelle Homeostasis and is a Targetable Pathway in Niemann-Pick type C

    Journal: Developmental cell

    doi: 10.1016/j.devcel.2020.11.016

    KEY RESOURCES TABLE
    Figure Legend Snippet: KEY RESOURCES TABLE

    Techniques Used: Labeling, Plasmid Preparation, Recombinant, Control, Software, Magnetic Beads



    Similar Products

    93
    Santa Cruz Biotechnology mouse monoclonal anti cln2 tpp1
    KEY RESOURCES TABLE
    Mouse Monoclonal Anti Cln2 Tpp1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal anti cln2 tpp1/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti cln2 tpp1 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    BioMarin Inc mouse anti-tpp1 monoclonal antibody
    KEY RESOURCES TABLE
    Mouse Anti Tpp1 Monoclonal Antibody, supplied by BioMarin Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-tpp1 monoclonal antibody/product/BioMarin Inc
    Average 90 stars, based on 1 article reviews
    mouse anti-tpp1 monoclonal antibody - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    93
    R&D Systems mouse monoclonal anti tpp1 antibody
    KEY RESOURCES TABLE
    Mouse Monoclonal Anti Tpp1 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal anti tpp1 antibody/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti tpp1 antibody - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    99
    Danaher Inc mouse monoclonal antibody against tpp1
    ( A ) Design of <t>LTM-TPP1</t> fusion protein and delivery schematic. ( B ) Enzyme kinetics of rTPP1 and LTM-TPP1 against the synthetic substrate AAF-AMC are indistinguishable. Michaelis-Menten plots were generated by varying [AAF-AMC] at a constant concentration of 10 nM enzyme (means ± SD; n = 3). Plots and kinetic parameters were calculated with GraphPad Prism 7.04. ( C ) Maturation of TPP1 is unaffected by the N-terminal fusion of LTM. ( D ) LTM-TPP1 inhibits wild-type DT activity in a dose-dependent manner (IC 50 of 17.2 nM), while rTPP1 has no effect on protein synthesis inhibition by DT (means ± SD; n = 3). ( E ) LTM and DTR-TPP1 bind HBEGF with apparent K d ’s of 13.3 and 19.1 nM, respectively. ( F ) LTM-TPP1 colocalizes with LAMP1 staining (red).
    Mouse Monoclonal Antibody Against Tpp1, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal antibody against tpp1/product/Danaher Inc
    Average 99 stars, based on 1 article reviews
    mouse monoclonal antibody against tpp1 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    Danaher Inc mouse monoclonal antibody ab54685 tpp1
    ( A ) Design of <t>LTM-TPP1</t> fusion protein and delivery schematic. ( B ) Enzyme kinetics of rTPP1 and LTM-TPP1 against the synthetic substrate AAF-AMC are indistinguishable. Michaelis-Menten plots were generated by varying [AAF-AMC] at a constant concentration of 10 nM enzyme (means ± SD; n = 3). Plots and kinetic parameters were calculated with GraphPad Prism 7.04. ( C ) Maturation of TPP1 is unaffected by the N-terminal fusion of LTM. ( D ) LTM-TPP1 inhibits wild-type DT activity in a dose-dependent manner (IC 50 of 17.2 nM), while rTPP1 has no effect on protein synthesis inhibition by DT (means ± SD; n = 3). ( E ) LTM and DTR-TPP1 bind HBEGF with apparent K d ’s of 13.3 and 19.1 nM, respectively. ( F ) LTM-TPP1 colocalizes with LAMP1 staining (red).
    Mouse Monoclonal Antibody Ab54685 Tpp1, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal antibody ab54685 tpp1/product/Danaher Inc
    Average 99 stars, based on 1 article reviews
    mouse monoclonal antibody ab54685 tpp1 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology mouse anti tpp1
    ( A ) Design of <t>LTM-TPP1</t> fusion protein and delivery schematic. ( B ) Enzyme kinetics of rTPP1 and LTM-TPP1 against the synthetic substrate AAF-AMC are indistinguishable. Michaelis-Menten plots were generated by varying [AAF-AMC] at a constant concentration of 10 nM enzyme (means ± SD; n = 3). Plots and kinetic parameters were calculated with GraphPad Prism 7.04. ( C ) Maturation of TPP1 is unaffected by the N-terminal fusion of LTM. ( D ) LTM-TPP1 inhibits wild-type DT activity in a dose-dependent manner (IC 50 of 17.2 nM), while rTPP1 has no effect on protein synthesis inhibition by DT (means ± SD; n = 3). ( E ) LTM and DTR-TPP1 bind HBEGF with apparent K d ’s of 13.3 and 19.1 nM, respectively. ( F ) LTM-TPP1 colocalizes with LAMP1 staining (red).
    Mouse Anti Tpp1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti tpp1/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    mouse anti tpp1 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    Image Search Results


    KEY RESOURCES TABLE

    Journal: Developmental cell

    Article Title: NPC1-mTORC1 signaling Couples Cholesterol Sensing to Organelle Homeostasis and is a Targetable Pathway in Niemann-Pick type C

    doi: 10.1016/j.devcel.2020.11.016

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: Mouse monoclonal anti-CLN2 (TPP1) , Santa Cruz Biotechnology , Cat#sc-393961.

    Techniques: Labeling, Plasmid Preparation, Recombinant, Control, Software, Magnetic Beads

    ( A ) Design of LTM-TPP1 fusion protein and delivery schematic. ( B ) Enzyme kinetics of rTPP1 and LTM-TPP1 against the synthetic substrate AAF-AMC are indistinguishable. Michaelis-Menten plots were generated by varying [AAF-AMC] at a constant concentration of 10 nM enzyme (means ± SD; n = 3). Plots and kinetic parameters were calculated with GraphPad Prism 7.04. ( C ) Maturation of TPP1 is unaffected by the N-terminal fusion of LTM. ( D ) LTM-TPP1 inhibits wild-type DT activity in a dose-dependent manner (IC 50 of 17.2 nM), while rTPP1 has no effect on protein synthesis inhibition by DT (means ± SD; n = 3). ( E ) LTM and DTR-TPP1 bind HBEGF with apparent K d ’s of 13.3 and 19.1 nM, respectively. ( F ) LTM-TPP1 colocalizes with LAMP1 staining (red).

    Journal: Science Advances

    Article Title: Exploiting the diphtheria toxin internalization receptor enhances delivery of proteins to lysosomes for enzyme replacement therapy

    doi: 10.1126/sciadv.abb0385

    Figure Lengend Snippet: ( A ) Design of LTM-TPP1 fusion protein and delivery schematic. ( B ) Enzyme kinetics of rTPP1 and LTM-TPP1 against the synthetic substrate AAF-AMC are indistinguishable. Michaelis-Menten plots were generated by varying [AAF-AMC] at a constant concentration of 10 nM enzyme (means ± SD; n = 3). Plots and kinetic parameters were calculated with GraphPad Prism 7.04. ( C ) Maturation of TPP1 is unaffected by the N-terminal fusion of LTM. ( D ) LTM-TPP1 inhibits wild-type DT activity in a dose-dependent manner (IC 50 of 17.2 nM), while rTPP1 has no effect on protein synthesis inhibition by DT (means ± SD; n = 3). ( E ) LTM and DTR-TPP1 bind HBEGF with apparent K d ’s of 13.3 and 19.1 nM, respectively. ( F ) LTM-TPP1 colocalizes with LAMP1 staining (red).

    Article Snippet: Membranes were then blocked for 1 hour with a 5% milk–tris-buffered saline (TBS) solution and incubated overnight at room temperature with a 1:100 dilution of mouse monoclonal antibody against TPP1 (Abcam, ab54685) in 5% milk-TBS.

    Techniques: Generated, Concentration Assay, Activity Assay, Inhibition, Staining

    ( A ) CLN2 knockout cells exhibit ~4% TPP1 activity relative to wild-type HeLa Kyoto cells (means ± SD; n = 3). ( B ) Western blotting against TPP1 reveals no detectable protein in the knockout cells. ( C ) (Left) In vitro maturation of pro-rTPP1 and LTM-TPP1 (16 ng) was analyzed by Western blot. (Right) TPP1 present in wild-type (WT) and TPP1 −/− cells, and TPP1 −/− cells treated with 100 nM rTPP1 and LTM-TPP1. ( D ) Uptake of rTPP1 and LTM-TPP1 into HeLa Kyoto TPP1 −/− cells was monitored by TPP1 activity (means ± SD; n = 4). ( E ) TPP1 activity present in HeLa Kyoto TPP1 −/− cells following a single treatment with 50 nM LTM-TPP1 (means ± SD; n = 3).

    Journal: Science Advances

    Article Title: Exploiting the diphtheria toxin internalization receptor enhances delivery of proteins to lysosomes for enzyme replacement therapy

    doi: 10.1126/sciadv.abb0385

    Figure Lengend Snippet: ( A ) CLN2 knockout cells exhibit ~4% TPP1 activity relative to wild-type HeLa Kyoto cells (means ± SD; n = 3). ( B ) Western blotting against TPP1 reveals no detectable protein in the knockout cells. ( C ) (Left) In vitro maturation of pro-rTPP1 and LTM-TPP1 (16 ng) was analyzed by Western blot. (Right) TPP1 present in wild-type (WT) and TPP1 −/− cells, and TPP1 −/− cells treated with 100 nM rTPP1 and LTM-TPP1. ( D ) Uptake of rTPP1 and LTM-TPP1 into HeLa Kyoto TPP1 −/− cells was monitored by TPP1 activity (means ± SD; n = 4). ( E ) TPP1 activity present in HeLa Kyoto TPP1 −/− cells following a single treatment with 50 nM LTM-TPP1 (means ± SD; n = 3).

    Article Snippet: Membranes were then blocked for 1 hour with a 5% milk–tris-buffered saline (TBS) solution and incubated overnight at room temperature with a 1:100 dilution of mouse monoclonal antibody against TPP1 (Abcam, ab54685) in 5% milk-TBS.

    Techniques: Knock-Out, Activity Assay, Western Blot, In Vitro

    Uptake of rTPP1 and LTM-TPP1 into HeLa Kyoto TPP1 −/− cells following EndoH treatment to remove N -glycan labeling (means ± SD; n = 3).

    Journal: Science Advances

    Article Title: Exploiting the diphtheria toxin internalization receptor enhances delivery of proteins to lysosomes for enzyme replacement therapy

    doi: 10.1126/sciadv.abb0385

    Figure Lengend Snippet: Uptake of rTPP1 and LTM-TPP1 into HeLa Kyoto TPP1 −/− cells following EndoH treatment to remove N -glycan labeling (means ± SD; n = 3).

    Article Snippet: Membranes were then blocked for 1 hour with a 5% milk–tris-buffered saline (TBS) solution and incubated overnight at room temperature with a 1:100 dilution of mouse monoclonal antibody against TPP1 (Abcam, ab54685) in 5% milk-TBS.

    Techniques: Glycoproteomics, Labeling

    ( A ) Assay schematic. ( B ) TPP1 activity in brain homogenates of 6-week-old mice injected with two doses (5 and 25 μg) of either rTPP1 or LTM-TPP1 (5 μg, P = 0.01; 25 μg, P = 0.002). ( C ) TPP1 activity in brain homogenates following a single 25-μg dose of LTM-TPP1, 1, 7, and 14 days postinjection. Data are presented as box and whisker plots, with whiskers representing minimum and maximum values from n ≥ 4 mice per group. Statistical significance was calculated using paired t tests with GraphPad Prism 7.04.

    Journal: Science Advances

    Article Title: Exploiting the diphtheria toxin internalization receptor enhances delivery of proteins to lysosomes for enzyme replacement therapy

    doi: 10.1126/sciadv.abb0385

    Figure Lengend Snippet: ( A ) Assay schematic. ( B ) TPP1 activity in brain homogenates of 6-week-old mice injected with two doses (5 and 25 μg) of either rTPP1 or LTM-TPP1 (5 μg, P = 0.01; 25 μg, P = 0.002). ( C ) TPP1 activity in brain homogenates following a single 25-μg dose of LTM-TPP1, 1, 7, and 14 days postinjection. Data are presented as box and whisker plots, with whiskers representing minimum and maximum values from n ≥ 4 mice per group. Statistical significance was calculated using paired t tests with GraphPad Prism 7.04.

    Article Snippet: Membranes were then blocked for 1 hour with a 5% milk–tris-buffered saline (TBS) solution and incubated overnight at room temperature with a 1:100 dilution of mouse monoclonal antibody against TPP1 (Abcam, ab54685) in 5% milk-TBS.

    Techniques: Activity Assay, Injection, Whisker Assay